Cencora’s $2.4 Billion American Oncology Network Deal Extends Healthcare Consolidation
Cencora’s $2.4 billion deal for American Oncology Network highlights the strategic pull of oncology services and pharmaceutical distribution.
United Airlines’ 2026 Outlook Shows How $100 Oil Is Squeezing Carriers
United Airlines’ reduced 2026 outlook highlights how volatile crude prices can pressure airline marg…
Cencora’s $2.4 Billion Oncology Acquisition Extends Healthcare Consolidation Trend
Cencora’s $2.4 billion acquisition of American Oncology Network highlights continued consolidation a…
Potential SpaceX-Tesla Merger Puts Shareholders, Nasdaq and Musk’s Empire in Focus
Exploratory merger committees at SpaceX and Tesla raise questions about valuation, governance, publi…
Data Center Stocks Face a New AI Valuation Test as Neocloud IPO Plunges
A 30% plunge in a Korea-listed IPO is testing AI infrastructure valuations as Anthropic and Nscale d…
GE Aerospace Raises 2026 Profit Outlook as Services Business Drives Growth
GE Aerospace lifted its 2026 profit outlook, with services strength offering a read on commercial av…
Salesforce’s Braze Deal Signals a New Test for Enterprise Software Valuations
Salesforce’s $47.50-per-share cash offer for Braze puts acquisition premiums, software valuations an…
Data Center and Neocloud Stocks Slide as Korean IPO Rout Tests AI Infrastructure Trade
A 30% plunge in a South Korean IPO rattled data center and neocloud stocks, raising questions about …
GE Aerospace Raises 2026 Earnings Outlook as Services Business Drives Growth
GE Aerospace lifted its 2026 earnings outlook, highlighting recurring engine maintenance demand as a…
Salesforce’s Braze Deal Signals Another Push Into Enterprise Marketing Technology
Salesforce’s reported $47.50-per-share cash acquisition of Braze highlights the strategic value of c…